William Blair Starts ARIAD Pharma (ARIA) at Outperform, $25 Target

Article Stock Quotes (1) Comments (0)

William Blair initiates coverage on ARIAD Pharmaceuticals (NASDAQ: ARIA) with a Outperform. The firm set a $25 price target, suggesting potential upside of about 32 percent from where the stock closed on Friday.

For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
• ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting
• BTIG Starts Ambac Financial (AMBC) at Buy, Interesting Play with 'Optionality'

Create E-mail Alert Related Categories

New Coverage

Related Entities

William Blair

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?